臨床試驗

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

NCT：NCT06084000 · ACTIVE_NOT_RECRUITING

NCT IDNCT06084000

狀態ACTIVE_NOT_RECRUITING

開始日期2023-10-15

完成時間2031-02-15

SponsorChina National Center for Cardiovascular Diseases (OTHER_GOV)

First posted2023-10-16

Last updated2026-09-10

簡要摘要

This is a multicenter, open-label, randomized controlled study meant to compare the safety and efficacy of scheduled drug-coated balloon (DCB) and conventional drug-eluting stent (DES) strategy in the treatment of de novo lesions of large coronary vessel with diameter larger than 2.75 mm. The trial was designed to provide high-quality evidence for expanding the clinical indications of DCB, and to explore a better way for coronary intervention based on DCB.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。